Pulmonary function deficits in newborn screened infants with cystic fibrosis managed with standard UK care are mild and transient
File(s)LCFC 2yr supplement - clean copy.docx (1.08 MB)
Supporting information
Author(s)
Type
Journal Article
Abstract
With the advent of novel designer molecules for cystic fibrosis (CF) treatment, there is huge need for early-life clinical trial outcomes, such as infant lung function (ILF). We investigated the degree and tracking of ILF abnormality during the first 2 years of life in CF newborn screened infants. Forced expiratory volume in 0.5 s (FEV0.5), lung clearance index (LCI) and plethysmographic functional residual capacity were measured at ∼3 months, 1 year and 2 years in 62 infants with CF and 34 controls. By 2 years there was no significant difference in FEV0.5 z-score between CF and controls, whereas mean LCI z-score was 0.81 (95% CI 0.45–1.17) higher in CF. However, there was no significant association between LCI z-score at 2 years with either 3-month or 1-year results. Despite minimal average group changes in any ILF outcome during the second year of life, marked within-subject changes occurred. No child had abnormal LCI or FEV0.5 on all test occasions, precluding the ability to identify “high-risk” infants in early life. In conclusion, changes in lung function are mild and transient during the first 2 years of life in newborn screened infants with CF when managed according to a standardised UK treatment protocol. Their potential role in tracking disease to later childhood will be ascertained by ongoing follow-up.
Date Issued
2017-11-09
Online Publication Date
2019-05-09T06:00:15Z
Date Acceptance
2017-08-03
ISSN
0903-1936
Publisher
European Respiratory Society
Journal / Book Title
European Respiratory Journal
Volume
50
Issue
5
Copyright Statement
Copyright ©ERS 2017
Subjects
Science & Technology
Life Sciences & Biomedicine
Respiratory System
LUNG CLEARANCE INDEX
CLINICAL-TRIAL
FUNCTION TESTS
END-POINTS
EVOLUTION
CHILDREN
INFECTION
DISEASE
LIFE
AGE
London Cystic Fibrosis Collaboration (LCFC)
11 Medical And Health Sciences
Publication Status
Published
Article Number
1700326